Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02862015Phase 2Unknown
Phase 2, randomised, open-label trial (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: European Organisation for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ)-C30 score change at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02862015.